Category Archives: Financial

“The Best Drug Companies Of The Past 15 Years?”

Matt Herper in Forbes’ “the Medicine Show” posts a point of view by Bernard Munos on what firms have done best in terms of approved drugs since 1995.  The link is here (, as are my comments on this provocative topic.  … Continue reading

Posted in Core Learnings, Financial, In the Pipeline | 1 Comment



Innovation Upturn? New Medical Entities /$ Increasing!

A recent posting on Derek Lowe’s “In the Pipeline” presents a dismal view of the returns on R&D in Pharma.   BCG had included a graph (from Bernstein Research) of the trend of new molecular entities (“nme”) per $B spent over … Continue reading

Posted in Financial, Innovation, New R&D models | Tagged , | 4 Comments



Continued laments on R&D performance

Poor performance of Pharma R&D seems to have never left the newsservices or the hearts of all in the industry.  It is interesting to see the stories of 2011 echoing back for a decade.  Here are some current “news” items … Continue reading

Posted in Core Learnings, Financial, General Interest, Uncategorized | 1 Comment



McKinsey article hits close to home…

While I have been using the name “R&D Returns” for years, I welcome this article from McKinsey.  Here, they call attention to the value of balanced R&D architecture and management.  Some of the sea-change tools cited on my home page here … Continue reading

Posted in Financial, General Interest, Research | Tagged , , | Leave a comment